Corporate Information - Narrative (Details) - USD ($) $ in Millions |
Dec. 31, 2019 |
May 31, 2013 |
|---|---|---|
| Subsequent Event [Line Items] | ||
| Cash, cash equivalents and investments | $ 104.2 | |
| Pieris Pharmaceuticals GmbH | ||
| Subsequent Event [Line Items] | ||
| Proportion of voting interests acquired (as a percent) | 100.00% |
| X | ||||||||||
- Definition Cash, Cash Equivalents, And Investments No definition available.
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|